Something better? Competitors can only offer new small iterations to upcoming valves (see Sapien X4).
The only threat would be a one piece non-bioprosphetic (spelling?) valve. I guess everybody, including us, is working on that. But at this point in time, Sapien X4 appears to be our future main competitor in 2027-28....
Further Update on Edwards, page-174
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.05 |
Change
-0.020(0.09%) |
Mkt cap ! $404.3M | |||
| Open | High | Low | Value | Volume |
| $21.00 | $21.05 | $20.70 | $193.2K | 9.289K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $21.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.05 | 999 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.93 |
Change
-0.020 ( 0.37 %) |
||||
| Open | High | Low | Volume | ||
| $20.93 | $20.93 | $20.93 | 81 | ||
| Last updated 12.16pm 10/05/2024 ? | |||||
| AVR (ASX) Chart |